Also, these patients had a lower Hb level, lower NT-proBNP, troponin levels, and the measurement of ventricular chambers was lower, indicating that these patients had associated other conditions that could lead to anemia and were treated with FCM. The gene discussed is GSTM1; the disease is anemia.